♀️
Our women's cancer program addresses ovarian, cervical, and endometrial cancers through innovative early-detection methods and PARP-inhibitor–based therapies.
Learn MoreOptimizing PARP inhibitor maintenance strategies based on homologous recombination deficiency status in ovarian cancer.
Developing and validating cfDNA-based tests for simultaneous detection of ovarian, endometrial, and cervical cancers.
HPV vaccination awareness programs and clinical trials of therapeutic HPV vaccines for pre-invasive disease.
NCT06234512
RecruitingPI: Dr. Rama Jayaraj
NCT06234513
ActivePI: Dr. Shirley Sunder Singh
Donations fund early detection research and clinical trials that give women diagnosed with ovarian and cervical cancers access to the most promising new therapies.
Donate Now
.png&w=96&q=75){kind=small}